The presence of all the elements necessary to trigger a host anticancer immune response (tumour-associated antigens, cross-presentation of antigens by DNGR-1+ dendritic cells, and infiltration of CD8+ T-cells and NK cells), as suggested above, does not always result in an effective immune response against the tumour. This evidence concerns the gene CLEC9A and neoplasm.